Skip to content

Retatrutide: Benefits & Research

Part of the Retatrutide Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Record Weight Loss

Retatrutide produced the highest weight loss ever recorded in a controlled anti-obesity trial:

DoseMean Weight Loss≥20% Loss
4 mg-17.1%40%
8 mg-22.8%60%
12 mg-24.2%63%

At 12mg, the weight loss curve had not plateaued at 48 weeks, suggesting even greater results with longer treatment. The triple mechanism — GLP-1 reducing appetite, GIP improving fat metabolism, glucagon increasing energy expenditure — attacks obesity from both intake and expenditure sides.

Liver Fat Reduction

A sub-study showed dramatic liver fat improvements:

  • 82% mean relative reduction in liver fat at 8mg dose
  • 86% of NAFLD patients achieved complete resolution (<5% liver fat)
  • Results far exceed any current NAFLD treatment

Type 2 Diabetes

HbA1c reduction of -2.02% and body weight loss of -16.9% over 36 weeks at 12mg in T2D patients. See the peptides for weight loss guide for comparisons with tirzepatide.

References

  1. Jastreboff AM, et al.. Triple-hormone-receptor agonist retatrutide for obesity — a Phase 2 trial. New England Journal of Medicine, 2023.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.